Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1.
Bosseboeuf A, Mennesson N, Allain-Maillet S, Tallet A, Piver E, Decaux O, Moreau C, Moreau P, Lehours P, Mégraud F, Salle V, Bigot-Corbel E, Harb J, Hermouet S. Bosseboeuf A, et al. Among authors: decaux o. Cancers (Basel). 2020 May 15;12(5):1254. doi: 10.3390/cancers12051254. Cancers (Basel). 2020. PMID: 32429322 Free PMC article.
Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?
Avet-Loiseau H, Malard F, Campion L, Magrangeas F, Sebban C, Lioure B, Decaux O, Lamy T, Legros L, Fuzibet JG, Michallet M, Corront B, Lenain P, Hulin C, Mathiot C, Attal M, Facon T, Harousseau JL, Minvielle S, Moreau P; Intergroupe Francophone du Myélome. Avet-Loiseau H, et al. Among authors: decaux o. Blood. 2011 Feb 10;117(6):2009-11. doi: 10.1182/blood-2010-07-295105. Epub 2010 Oct 20. Blood. 2011. PMID: 20962323 Free article. Clinical Trial.
Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients.
Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E; Intergroupe Francophone du Myélome. Decaux O, et al. Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):418-22. doi: 10.1016/j.clml.2012.06.003. Epub 2012 Sep 29. Clin Lymphoma Myeloma Leuk. 2012. PMID: 23025991 Clinical Trial.
Long-term outcome of monoclonal (type 1) cryoglobulinemia.
Néel A, Perrin F, Decaux O, Dejoie T, Tessoulin B, Halliez M, Mahé B, Lamy T, Fakhouri F, Jego P, Agard C, Vigneau C, Guenet L, Grosbois B, Moreau P, Hamidou M. Néel A, et al. Among authors: decaux o. Am J Hematol. 2014 Feb;89(2):156-61. doi: 10.1002/ajh.23608. Am J Hematol. 2014. PMID: 24532335 Free article.
Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP, Moreau C, Besnard S, Latute F, Collet N, Sebillot M, Grosbois B, Bendavid C, Guenet L, Decaux O. Beaumont-Epinette MP, et al. Among authors: decaux o. Pathol Biol (Paris). 2015 Sep;63(4-5):215-21. doi: 10.1016/j.patbio.2015.06.001. Epub 2015 Aug 28. Pathol Biol (Paris). 2015. PMID: 26319969 Clinical Trial.
Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
Henriot B, Rouger E, Rousseau C, Escoffre M, Sébillot M, Bendavid C, Minvielle S, Avet-Loiseau H, Decaux O, Moreau C. Henriot B, et al. Among authors: decaux o. Clin Chem Lab Med. 2019 Aug 27;57(9):1397-1405. doi: 10.1515/cclm-2018-1369. Clin Chem Lab Med. 2019. PMID: 30973821 Free article.
New insights in the treatment of patients with solitary bone plasmacytoma.
Mheidly K, Lamy De La Chapelle T, Hunault M, Benboubker L, Benchalal M, Moreau P, Baugier de Materre A, Decaux O, Laribi K. Mheidly K, et al. Among authors: decaux o. Leuk Lymphoma. 2019 Nov;60(11):2810-2813. doi: 10.1080/10428194.2019.1605067. Epub 2019 Apr 25. Leuk Lymphoma. 2019. PMID: 31020888 No abstract available.
Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.
Perrot A, Lauwers-Cances V, Tournay E, Hulin C, Chretien ML, Royer B, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Fontan J, Voillat L, Demarquette H, Collet P, Rodon P, Sohn C, Lifermann F, Orsini-Piocelle F, Richez V, Mohty M, Macro M, Minvielle S, Moreau P, Leleu X, Facon T, Attal M, Avet-Loiseau H, Corre J. Perrot A, et al. Among authors: decaux o. J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15. J Clin Oncol. 2019. PMID: 31091136 Free PMC article. Clinical Trial.
166 results